Kiniksa Pharmaceuticals Ltd.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -1.88%162.110.7%$1086.81m
MRKMerck & Co., Inc. -0.79%76.620.7%$1018.44m
PFEPfizer Inc. -1.77%38.780.9%$918.56m
LLYEli Lilly & Co. -1.68%218.471.1%$906.20m
ABBVAbbVie, Inc. -1.59%113.071.9%$727.29m
BMYBristol-Myers Squibb Co. -0.34%66.541.0%$643.98m
AZNAstraZeneca Plc 0.03%58.371.2%$408.15m
ANVSAnnovis Bio, Inc. 2.78%92.550.0%$317.09m
OGN -4.74%29.970.0%$312.13m
NVSNovartis AG -1.21%93.010.2%$178.45m
GSKGlaxoSmithKline Plc -1.80%39.840.2%$160.18m
ORPHOrphazyme A/S -49.66%7.330.0%$152.39m
NOVNNovan, Inc. 0.18%10.875.8%$140.49m
CVACCureVac NV 7.11%61.940.0%$108.62m
CNSTConstellation Pharmaceuticals, Inc. -0.18%33.760.0%$107.09m

Company Profile

Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Hamilton, Bermuda.